— Know what they know.
Not Investment Advice
Also trades as: 0R0H.L (LSE) · $vol 6M · TMO.NE (NEO) · $vol 0M · TN8.DE (XETRA) · $vol 0M

TMO NYSE

Thermo Fisher Scientific Inc.
1W: +0.3% 1M: -12.6% 3M: -12.1% YTD: -24.2% 1Y: +8.9% 3Y: -12.8% 5Y: -0.9%
$448.28
-1.09 (-0.24%)
 
Weekly Expected Move ±5.6%
$389 $414 $438 $463 $487
NYSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Strong Sell · Power 37 · $166.6B mcap · 371M float · 0.579% daily turnover · Short 31% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WIDE EDGE
73.3 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 8.9%  ·  5Y Avg: 10.6%
Cost Advantage
60
Intangibles
83
Switching Cost
78
Network Effect
50
Scale ★
90
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TMO possesses a Wide competitive edge (73.3/100) — durable structural advantages that are difficult for competitors to erode. The primary source of advantage is Efficient Scale. ROIC of 8.9% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$490
Low
$587
Avg Target
$639
High
Based on 4 analysts since Apr 23, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 38Hold: 4Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$587.25
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-14 RBC Capital $561 $490 -71 +9.3% $448.21
2026-04-27 Morgan Stanley Kallum Titchmarsh $656 $620 -36 +31.3% $472.23
2026-04-24 Stifel Nicolaus Daniel Arias $700 $600 -100 +28.4% $467.47
2026-04-24 Robert W. Baird Catherine Ramsey Schulte $653 $639 -14 +36.9% $466.70
2026-01-30 UBS $590 $615 +25 +6.1% $579.86
2026-01-30 Wells Fargo $675 $683 +8 +17.7% $580.09
2026-01-30 Robert W. Baird $622 $653 +31 +12.0% $583.12
2026-01-30 Barclays $625 $650 +25 +9.8% $592.16
2026-01-09 Stifel Nicolaus Daniel Arias $680 $700 +20 +15.4% $606.50
2026-01-05 Evercore ISI Vijay Kumar $585 $650 +65 +7.3% $605.83
2025-12-15 Wells Fargo $505 $675 +170 +18.0% $571.99
2025-12-09 Goldman Sachs Evie Koslosky $610 $685 +75 +20.6% $568.21
2025-12-07 KeyBanc Paul Knight $710 $750 +40 +30.9% $572.77
2025-10-29 Argus Research $600 $610 +10 +6.9% $570.82
2025-10-28 Morgan Stanley $678 $656 -22 +16.5% $563.28
2025-10-23 UBS $460 $590 +130 +3.2% $571.67
2025-10-23 Barclays $585 $625 +40 +10.2% $567.20
2025-10-22 Leerink Partners $630 $580 -50 +2.3% $567.20
2025-10-08 Redburn Partners $580 $575 -5 +7.2% $536.19
2025-10-08 Redburn Partners Initiated $580 +7.6% $539.17
2025-10-02 Barclays Luke Sergott $610 $585 -25 +10.2% $530.73
2025-09-02 RBC Capital Conor McNamara $693 $561 -132 +15.1% $487.53
2025-07-08 UBS Dan Leonard Initiated $460 +7.9% $426.17
2025-04-25 Scotiabank Initiated $605 +42.6% $424.24
2025-04-23 Goldman Sachs Matthew Sykes $690 $610 -80 +41.3% $431.64
2025-01-31 RBC Capital Conor McNamara $661 $693 +32 +15.9% $597.75
2025-01-02 Evercore ISI Vijay Kumar $630 $585 -45 +11.9% $522.57
2024-10-24 Robert W. Baird Catherine Schulte $632 $622 -10 +7.9% $576.49
2024-10-23 Barclays Luke Sergott $600 $610 +10 +6.8% $570.92
2024-10-01 Evercore ISI Vijay Kumar Initiated $630 +1.8% $618.57
2024-09-20 Stifel Nicolaus Daniel Arias Initiated $680 +9.6% $620.25
2024-09-20 Robert W. Baird Catherine Schulte Initiated $632 +1.9% $620.25
2024-09-19 Citigroup Patrick Donnelly $700 $620 -80 +0.5% $617.11
2024-09-18 Deutsche Bank Justin Bowers $610 $630 +20 +3.4% $609.41
2024-09-16 Bank of America Securities Derik de Bruin $670 $675 +5 +10.4% $611.17
2024-07-25 Raymond James Andrew Cooper $530 $660 +130 +11.1% $593.86
2024-06-28 Barclays Luke Sergott $615 $600 -15 +8.9% $550.78
2024-04-30 HSBC Sidharth Sahoo Initiated $670 +16.1% $576.89
2024-04-25 Deutsche Bank Justin Bowers $620 $610 -10 +5.6% $577.39
2024-04-25 Barclays Luke Sergott $660 $615 -45 +6.5% $577.39
2023-10-26 Raymond James Andrew Cooper Initiated $530 +19.2% $444.45
2023-07-13 Credit Suisse Thermo Fisher Initiated $620 +18.0% $525.63
2023-02-02 Cowen & Co. Initiated $711 +20.1% $591.95
2023-02-02 Citigroup Initiated $700 +18.7% $589.73
2023-02-02 Barclays $570 $660 +90 +12.4% $587.36
2023-02-01 Leerink Partners $620 $630 +10 +7.3% $587.36
2023-01-06 Leerink Partners $650 $620 -30 +16.3% $532.88
2023-01-03 Wells Fargo $525 $505 -20 -8.7% $553.18
2022-12-14 Deutsche Bank Initiated $620 +8.5% $571.38
2022-12-06 RBC Capital Initiated $661 +20.1% $550.53

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
4
ROE
4
ROA
5
D/E
1
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TMO receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-11 B B+
2026-05-06 B+ B
2026-05-05 B B+
2026-05-04 B+ B
2026-05-01 B B+
2026-04-30 B+ B
2026-04-01 B B+
2026-01-03 B+ B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

60 Grade A
Profitability
52
Balance Sheet
58
Earnings Quality
73
Growth
47
Value
51
Momentum
75
Safety
80
Cash Flow
57
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TMO scores highest in Safety (80/100) and lowest in Growth (47/100). An overall grade of A places TMO among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.43
Safe Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.40
Unlikely Manipulator
Ohlson O-Score
-9.13
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A-
Score: 69.7/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.21x
Accruals: -1.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TMO scores 3.43, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TMO scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TMO's score of -2.40 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TMO's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TMO receives an estimated rating of A- (score: 69.7/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). TMO's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
24.24x
PEG
3.70x
P/S
3.67x
P/B
3.20x
P/FCF
26.17x
P/OCF
21.31x
EV/EBITDA
18.57x
EV/Revenue
4.59x
EV/EBIT
23.95x
EV/FCF
30.72x
Earnings Yield
3.88%
FCF Yield
3.82%
Shareholder Yield
2.63%
Graham Number
$243.40
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 24.2x earnings, TMO commands a growth premium. Graham's intrinsic value formula yields $243.40 per share, 84% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.927
NI / EBT
×
Interest Burden
0.854
EBT / EBIT
×
EBIT Margin
0.192
EBIT / Rev
×
Asset Turnover
0.435
Rev / Assets
×
Equity Multiplier
2.016
Assets / Equity
=
ROE
13.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TMO's ROE of 13.3% is driven by Asset Turnover (0.435), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.93 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
5.80%
Fair P/E
20.11x
Intrinsic Value
$369.74
Price/Value
1.28x
Margin of Safety
-28.03%
Premium
28.03%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with TMO's realized 5.8% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. TMO trades at a 28% premium to its adjusted intrinsic value of $369.74, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 20.1x compares to the current market P/E of 24.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$448.24
Median 1Y
$464.75
5th Pctile
$291.54
95th Pctile
$739.49
Ann. Volatility
28.2%
Analyst Target
$587.25
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Marc N. Casper
Chairman, President and Chief Executive Officer
$1,785,534 $65,730,211 $79,923,350
Michel Lagarde Operating
Vice President and Chief Operating Officer
$1,166,433 $3,572,991 $8,907,174
Gianluca Pettiti
Executive Vice President
$1,031,918 $3,293,754 $8,080,467
Stephen Williamson Financial
ce President and Chief Financial Officer
$1,095,170 $2,456,033 $6,781,012
Frederick Lowery
Executive Vice President
$930,356 $2,623,683 $6,575,821

CEO Pay Ratio

1374:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $79,923,350
Avg Employee Cost (SGA/emp): $58,176
Employees: 125,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
125,000
0.0% YoY
Revenue / Employee
$356,448
Rev: $44,556,000,000
Profit / Employee
$53,896
NI: $6,737,000,000
SGA / Employee
$58,176
Avg labor cost proxy
R&D / Employee
$11,176
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 26.8% 26.7% 20.5% 20.2% 19.8% 18.7% 16.4% 14.2% 13.5% 14.0% 13.2% 13.3% 13.7% 13.5% 13.2% 13.5% 13.7% 13.6% 13.0% 13.3% 13.32%
ROA 13.5% 13.4% 9.4% 9.3% 9.1% 8.6% 7.2% 6.3% 6.0% 6.2% 6.1% 6.2% 6.4% 6.3% 6.5% 6.6% 6.7% 6.7% 6.5% 6.6% 6.61%
ROIC 20.1% 20.1% 12.5% 12.3% 11.9% 11.5% 10.8% 9.6% 9.6% 9.9% 9.5% 9.2% 9.0% 8.9% 9.0% 9.4% 9.7% 9.6% 8.8% 8.9% 8.86%
ROCE 17.8% 17.7% 11.5% 11.2% 11.1% 10.5% 10.7% 9.4% 9.0% 9.5% 9.2% 9.5% 10.0% 10.0% 10.3% 10.2% 10.2% 10.2% 9.1% 9.1% 9.10%
Gross Margin 48.9% 49.8% 46.1% 46.4% 41.8% 40.5% 36.3% 39.1% 39.9% 41.0% 36.3% 40.8% 41.2% 41.0% 39.2% 41.0% 37.3% 41.8% 38.0% 40.7% 40.67%
Operating Margin 24.3% 25.2% 25.0% 24.0% 17.7% 16.5% 17.3% 15.9% 16.7% 18.7% 18.3% 16.6% 16.7% 18.1% 19.9% 17.8% 17.7% 17.5% 18.8% 16.9% 16.93%
Net Margin 19.7% 20.4% 15.5% 18.7% 15.2% 14.0% 13.8% 12.0% 12.7% 16.2% 15.0% 12.8% 14.7% 15.4% 16.1% 14.5% 14.9% 14.5% 16.2% 15.0% 15.00%
EBITDA Margin 30.5% 31.4% 25.3% 29.9% 26.4% 24.5% 25.3% 23.5% 24.4% 28.5% 27.8% 26.9% 28.2% 27.4% 26.9% 25.4% 25.8% 25.5% 26.3% 21.0% 20.99%
FCF Margin 21.3% 20.3% 17.9% 17.6% 15.3% 13.2% 15.4% 12.8% 13.5% 15.1% 16.2% 17.8% 18.8% 18.4% 16.9% 15.7% 14.3% 14.0% 14.1% 14.9% 14.93%
OCF Margin 26.8% 26.1% 24.3% 23.8% 21.2% 18.9% 20.4% 17.5% 17.7% 18.8% 19.6% 21.0% 22.1% 21.5% 20.2% 19.0% 17.5% 17.5% 17.5% 18.3% 18.34%
ROE 3Y Avg snapshot only 12.96%
ROE 5Y Avg snapshot only 14.25%
ROA 3Y Avg snapshot only 6.34%
ROIC 3Y Avg snapshot only 8.91%
ROIC Economic snapshot only 7.99%
Cash ROA snapshot only 7.51%
Cash ROIC snapshot only 9.85%
CROIC snapshot only 8.02%
NOPAT Margin snapshot only 16.50%
Pretax Margin snapshot only 16.36%
R&D / Revenue snapshot only 3.08%
SGA / Revenue snapshot only 17.52%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 23.37 26.24 34.00 30.45 28.75 28.22 30.86 36.82 35.12 32.83 34.14 36.78 33.88 38.29 31.34 29.02 23.40 26.69 32.53 25.74 24.235
P/S Ratio 5.25 5.75 6.70 5.63 4.99 4.49 4.78 5.06 4.62 4.49 4.78 5.22 4.98 5.54 4.63 4.41 3.57 4.01 4.90 3.91 3.674
P/B Ratio 5.82 6.51 6.44 5.68 5.24 4.87 4.88 5.04 4.57 4.44 4.38 4.75 4.51 5.03 4.00 3.81 3.11 3.54 4.09 3.31 3.200
P/FCF 24.70 28.39 37.41 32.01 32.57 34.04 31.04 39.47 34.32 29.80 29.55 29.36 26.47 30.22 27.32 28.12 24.97 28.69 34.71 26.17 26.165
P/OCF 19.59 22.05 27.52 23.70 23.59 23.75 23.43 28.88 26.12 23.87 24.35 24.86 22.55 25.82 22.91 23.23 20.33 22.92 27.94 21.31 21.306
EV/EBITDA 16.47 18.37 24.62 21.95 20.36 19.60 20.27 22.82 21.47 20.17 20.87 21.89 20.27 22.52 19.23 18.68 15.90 17.87 21.71 18.57 18.574
EV/Revenue 5.57 6.07 7.51 6.40 5.74 5.21 5.39 5.69 5.25 5.13 5.44 5.89 5.65 6.21 5.26 5.04 4.20 4.63 5.59 4.59 4.587
EV/EBIT 20.33 22.81 31.43 28.73 27.11 26.98 28.27 33.03 31.56 29.20 30.02 31.09 28.20 31.02 26.16 25.14 21.26 23.73 28.65 23.95 23.950
EV/FCF 26.20 29.94 41.95 36.42 37.42 39.50 35.02 44.37 39.03 34.00 33.64 33.11 30.03 33.86 31.07 32.16 29.38 33.15 39.60 30.72 30.721
Earnings Yield 4.3% 3.8% 2.9% 3.3% 3.5% 3.5% 3.2% 2.7% 2.8% 3.0% 2.9% 2.7% 3.0% 2.6% 3.2% 3.4% 4.3% 3.7% 3.1% 3.9% 3.88%
FCF Yield 4.0% 3.5% 2.7% 3.1% 3.1% 2.9% 3.2% 2.5% 2.9% 3.4% 3.4% 3.4% 3.8% 3.3% 3.7% 3.6% 4.0% 3.5% 2.9% 3.8% 3.82%
PEG Ratio snapshot only 3.700
EV/OCF snapshot only 25.016
EV/Gross Profit snapshot only 11.639
Acquirers Multiple snapshot only 25.833
Shareholder Yield snapshot only 2.63%
Graham Number snapshot only $243.40
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.13 2.13 1.50 1.50 1.50 1.50 1.48 1.48 1.48 1.48 1.75 1.75 1.75 1.75 1.66 1.66 1.66 1.66 1.89 1.89 1.890
Quick Ratio 1.74 1.74 1.12 1.12 1.12 1.12 1.15 1.15 1.15 1.15 1.39 1.39 1.39 1.39 1.29 1.29 1.29 1.29 1.53 1.53 1.533
Debt/Equity 0.65 0.65 0.89 0.89 0.89 0.89 0.82 0.82 0.82 0.82 0.78 0.78 0.78 0.78 0.66 0.66 0.66 0.66 0.76 0.76 0.765
Net Debt/Equity 0.35 0.35 0.78 0.78 0.78 0.78 0.63 0.63 0.63 0.63 0.61 0.61 0.61 0.61 0.55 0.55 0.55 0.55 0.58 0.58 0.576
Debt/Assets 0.33 0.33 0.38 0.38 0.38 0.38 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.34 0.34 0.34 0.34 0.37 0.37 0.370
Debt/EBITDA 1.74 1.75 3.04 3.03 3.01 3.09 3.02 3.30 3.39 3.27 3.26 3.19 3.09 3.12 2.79 2.83 2.88 2.89 3.56 3.66 3.661
Net Debt/EBITDA 0.94 0.95 2.66 2.66 2.64 2.71 2.31 2.52 2.59 2.50 2.54 2.48 2.40 2.42 2.32 2.35 2.39 2.40 2.68 2.75 2.755
Interest Coverage 19.52 19.94 17.48 16.76 15.82 13.82 11.79 8.48 6.78 5.92 5.30 5.27 5.23 5.14 5.42 5.61 5.63 5.94 6.13 5.89 5.888
Equity Multiplier 2.00 2.00 2.33 2.33 2.33 2.33 2.21 2.21 2.21 2.21 2.11 2.11 2.11 2.11 1.96 1.96 1.96 1.96 2.07 2.07 2.066
Cash Ratio snapshot only 0.666
Debt Service Coverage snapshot only 7.593
Cash to Debt snapshot only 0.247
FCF to Debt snapshot only 0.165
Defensive Interval snapshot only 770.9 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.60 0.61 0.48 0.50 0.52 0.54 0.47 0.46 0.45 0.45 0.44 0.43 0.43 0.43 0.44 0.44 0.44 0.45 0.43 0.44 0.435
Inventory Turnover 5.11 5.24 4.38 4.74 5.10 5.47 4.94 4.97 4.98 4.96 4.87 4.80 4.76 4.76 5.07 5.07 5.19 5.23 5.19 5.26 5.265
Receivables Turnover 7.58 7.74 5.72 6.00 6.24 6.44 5.58 5.44 5.41 5.40 5.25 5.20 5.18 5.19 4.81 4.81 4.84 4.90 4.41 4.48 4.477
Payables Turnover 9.22 9.47 7.89 8.54 9.19 9.86 8.44 8.50 8.51 8.48 8.35 8.23 8.16 8.16 8.57 8.57 8.77 8.85 8.05 8.17 8.173
DSO 48 47 64 61 58 57 65 67 67 68 70 70 70 70 76 76 75 74 83 82 81.5 days
DIO 71 70 83 77 72 67 74 73 73 74 75 76 77 77 72 72 70 70 70 69 69.3 days
DPO 40 39 46 43 40 37 43 43 43 43 44 44 45 45 43 43 42 41 45 45 44.7 days
Cash Conversion Cycle 80 78 101 95 90 86 96 98 98 98 101 102 102 102 105 105 104 103 108 106 106.2 days
Fixed Asset Turnover snapshot only 3.763
Operating Cycle snapshot only 150.9 days
Cash Velocity snapshot only 4.471
Capital Intensity snapshot only 2.441
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 45.7% 37.1% 21.7% 14.6% 11.9% 13.1% 14.5% 6.5% 1.6% -1.7% -4.6% -3.0% -2.7% -2.4% 0.1% 1.0% 2.0% 3.2% 3.9% 5.4% 5.36%
Net Income 1.3% 75.5% 21.2% -4.1% -13.5% -17.9% -10.0% -20.8% -23.1% -15.5% -13.7% 0.2% 8.7% 3.3% 5.7% 8.0% 5.8% 7.1% 6.0% 5.3% 5.28%
EPS 1.3% 76.4% 21.8% -3.6% -13.0% -17.5% -8.9% -19.3% -21.9% -14.0% -12.6% 1.2% 10.2% 4.4% 7.1% 9.4% 7.2% 8.8% 7.7% 7.0% 6.97%
FCF 91.6% 39.2% 3.0% -10.3% -19.2% -26.3% -1.6% -22.3% -10.9% 12.3% 0.2% 34.5% 36.0% 18.8% 4.9% -11.1% -22.5% -21.4% -13.4% 0.4% 0.36%
EBITDA 90.1% 56.9% 18.4% -0.6% -6.7% -8.9% -0.2% -8.9% -11.9% -6.1% -6.5% 4.6% 10.9% 5.9% 5.1% 1.3% -3.4% -3.1% -2.2% -3.6% -3.61%
Op. Income 1.3% 78.5% 30.7% 0.7% -9.6% -14.7% -17.7% -27.0% -26.3% -19.3% -12.6% 1.1% 3.0% -0.8% 2.8% 4.2% 6.7% 7.9% 4.4% 3.1% 3.12%
OCF Growth snapshot only 1.82%
Asset Growth snapshot only 13.38%
Equity Growth snapshot only 7.71%
Debt Growth snapshot only 24.65%
Shares Change snapshot only -1.58%
Dividend Growth snapshot only 8.71%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 18.3% 17.8% 17.2% 18.6% 19.9% 20.5% 20.7% 19.5% 18.4% 15.1% 10.0% 5.8% 3.4% 2.7% 3.0% 1.4% 0.3% -0.3% -0.3% 1.0% 1.05%
Revenue 5Y 16.8% 16.8% 16.5% 17.0% 17.4% 17.4% 16.5% 14.8% 13.5% 12.7% 12.0% 11.5% 11.2% 10.9% 10.9% 10.8% 10.5% 8.9% 6.7% 4.7% 4.72%
EPS 3Y 54.0% 50.1% 38.8% 34.7% 28.8% 26.0% 24.4% 19.2% 16.6% 7.8% -1.0% -7.7% -9.2% -9.5% -5.2% -3.7% -2.7% -0.8% 0.2% 5.8% 5.80%
EPS 5Y 33.9% 33.9% 30.7% 28.4% 26.8% 25.0% 26.3% 22.8% 19.9% 19.1% 16.3% 14.8% 12.9% 12.4% 12.5% 13.4% 13.3% 7.3% 2.2% -1.6% -1.63%
Net Income 3Y 53.1% 49.4% 38.0% 33.8% 28.1% 25.1% 23.4% 18.0% 15.6% 6.8% -2.0% -8.7% -10.2% -10.5% -6.4% -5.0% -4.0% -2.2% -1.1% 4.4% 4.42%
Net Income 5Y 33.9% 33.8% 30.7% 28.5% 26.8% 24.8% 25.6% 21.7% 19.0% 18.3% 15.3% 13.7% 11.9% 11.3% 11.4% 12.2% 12.2% 6.1% 1.0% -2.8% -2.85%
EBITDA 3Y 31.9% 29.0% 24.5% 23.4% 20.0% 18.8% 19.4% 16.1% 16.0% 10.3% 3.4% -1.8% -3.0% -3.2% -0.6% -1.2% -1.9% -1.2% -1.3% 0.7% 0.70%
EBITDA 5Y 24.9% 25.0% 22.3% 21.9% 21.4% 19.9% 18.8% 15.5% 13.6% 12.9% 12.5% 12.4% 11.1% 10.8% 10.8% 10.6% 10.9% 6.6% 2.6% -1.6% -1.56%
Gross Profit 3Y 24.3% 23.9% 22.3% 22.4% 22.1% 20.9% 18.9% 15.9% 13.4% 8.7% 2.1% -2.7% -4.5% -5.0% -3.5% -3.9% -4.5% -3.4% -1.8% 1.1% 1.08%
Gross Profit 5Y 18.0% 18.1% 17.3% 17.2% 17.0% 16.0% 14.9% 12.4% 10.9% 10.4% 9.6% 9.4% 9.3% 9.0% 9.5% 9.5% 8.0% 5.7% 2.2% -0.4% -0.44%
Op. Income 3Y 44.7% 43.0% 38.8% 36.6% 34.1% 30.2% 26.0% 20.1% 15.8% 7.1% -2.0% -9.4% -11.8% -11.9% -9.5% -8.4% -6.8% -4.7% -2.1% 2.8% 2.80%
Op. Income 5Y 35.1% 33.6% 30.9% 28.5% 26.5% 24.3% 21.2% 16.8% 15.1% 15.0% 14.0% 13.4% 12.8% 12.1% 12.5% 12.8% 11.3% 5.6% 0.2% -4.4% -4.40%
FCF 3Y 30.1% 26.4% 22.9% 19.2% 17.1% 14.0% 19.5% 14.9% 11.3% 4.8% 0.5% -2.1% -0.7% -0.6% 1.2% -2.4% -2.1% 1.6% -3.1% 6.3% 6.29%
FCF 5Y 24.8% 23.7% 21.0% 20.8% 18.7% 14.8% 14.6% 12.0% 9.7% 10.8% 12.8% 12.1% 14.3% 14.6% 12.4% 12.7% 7.8% 1.5% -1.6% -3.5% -3.50%
OCF 3Y 33.4% 30.3% 28.1% 24.1% 22.2% 19.8% 22.6% 18.0% 13.4% 6.0% 0.5% -3.4% -3.0% -3.7% -3.2% -5.9% -5.8% -2.9% -5.1% 2.6% 2.56%
OCF 5Y 26.6% 26.2% 24.8% 24.8% 23.3% 20.1% 18.0% 15.6% 12.2% 12.1% 13.1% 11.8% 13.5% 13.4% 11.8% 11.7% 7.5% 2.2% -1.2% -3.5% -3.52%
Assets 3Y 6.8% 6.8% 19.2% 19.2% 19.2% 19.2% 18.5% 18.5% 18.5% 18.5% 12.7% 12.7% 12.7% 12.7% 0.8% 0.8% 0.8% 0.8% 4.3% 4.3% 4.33%
Assets 5Y 11.1% 11.1% 15.7% 15.7% 15.7% 15.7% 11.4% 11.4% 11.4% 11.4% 11.9% 11.9% 11.9% 11.9% 10.8% 10.8% 10.8% 10.8% 9.8% 9.8% 9.83%
Equity 3Y 10.7% 10.7% 13.9% 13.9% 13.9% 13.9% 14.0% 14.0% 14.0% 14.0% 10.6% 10.6% 10.6% 10.6% 6.7% 6.7% 6.7% 6.7% 6.7% 6.7% 6.69%
Book Value 3Y 11.4% 11.3% 14.6% 14.7% 14.5% 14.8% 14.9% 15.2% 15.0% 15.1% 11.8% 11.9% 11.9% 11.9% 8.1% 8.2% 8.2% 8.3% 8.2% 8.1% 8.10%
Dividend 3Y 5.4% 5.6% 6.1% 6.4% 5.9% 6.0% 5.6% 5.6% 5.5% 5.5% 5.8% 6.0% 5.6% 5.3% 5.0% 4.8% 4.6% 4.5% 4.4% 4.2% 4.18%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.82 0.87 0.93 0.91 0.89 0.92 0.95 0.93 0.89 0.90 0.92 0.88 0.80 0.75 0.74 0.71 0.66 0.62 0.62 0.74 0.743
Earnings Stability 0.69 0.80 0.90 0.83 0.79 0.83 0.88 0.65 0.53 0.56 0.56 0.33 0.24 0.20 0.20 0.06 0.03 0.00 0.09 0.33 0.331
Margin Stability 0.93 0.93 0.94 0.93 0.94 0.94 0.92 0.90 0.91 0.91 0.90 0.89 0.89 0.90 0.91 0.92 0.92 0.92 0.90 0.88 0.882
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.92 0.98 0.95 0.93 0.96 0.92 0.91 0.94 0.95 1.00 0.97 0.99 0.98 0.97 0.98 0.97 0.98 0.98 0.979
Earnings Smoothness 0.21 0.45 0.81 0.96 0.86 0.80 0.89 0.77 0.74 0.83 0.85 1.00 0.92 0.97 0.94 0.92 0.94 0.93 0.94 0.95 0.949
ROE Trend 0.12 0.10 0.03 0.01 -0.00 -0.03 -0.03 -0.07 -0.09 -0.08 -0.05 -0.03 -0.02 -0.02 -0.02 -0.00 0.00 -0.00 -0.00 -0.00 -0.002
Gross Margin Trend 0.07 0.06 0.03 0.01 -0.02 -0.05 -0.08 -0.10 -0.09 -0.08 -0.06 -0.04 -0.03 -0.02 0.00 0.01 0.00 0.00 -0.00 -0.01 -0.006
FCF Margin Trend 0.05 0.02 -0.01 -0.01 -0.03 -0.07 -0.04 -0.07 -0.05 -0.02 -0.00 0.03 0.04 0.04 0.01 0.00 -0.02 -0.03 -0.02 -0.02 -0.018
Sustainable Growth Rate 25.7% 25.5% 19.5% 19.1% 18.6% 17.5% 15.3% 13.1% 12.3% 12.8% 12.1% 12.1% 12.5% 12.3% 11.9% 12.3% 12.4% 12.3% 11.8% 12.1% 12.06%
Internal Growth Rate 14.8% 14.7% 9.8% 9.6% 9.3% 8.7% 7.2% 6.1% 5.8% 6.0% 5.9% 5.9% 6.1% 6.0% 6.2% 6.4% 6.5% 6.5% 6.2% 6.4% 6.36%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.19 1.19 1.24 1.28 1.22 1.19 1.32 1.28 1.34 1.38 1.40 1.48 1.50 1.48 1.37 1.25 1.15 1.16 1.16 1.21 1.208
FCF/OCF 0.79 0.78 0.74 0.74 0.72 0.70 0.75 0.73 0.76 0.80 0.82 0.85 0.85 0.85 0.84 0.83 0.81 0.80 0.80 0.81 0.814
FCF/Net Income snapshot only 0.984
OCF/EBITDA snapshot only 0.742
CapEx/Revenue 5.5% 5.8% 6.4% 6.2% 5.8% 5.7% 5.0% 4.7% 4.2% 3.7% 3.5% 3.2% 3.3% 3.1% 3.3% 3.3% 3.3% 3.5% 3.4% 3.4% 3.41%
CapEx/Depreciation snapshot only 0.614
Accruals Ratio -0.03 -0.03 -0.02 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.03 -0.03 -0.03 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.014
Sloan Accruals snapshot only 0.021
Cash Flow Adequacy snapshot only 3.787
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.3% 0.3% 0.2% 0.3% 0.2% 0.3% 0.3% 0.4% 0.4% 0.3% 0.4% 0.39%
Dividend/Share $0.92 $0.95 $0.99 $1.04 $1.08 $1.12 $1.16 $1.21 $1.26 $1.30 $1.35 $1.41 $1.45 $1.48 $1.52 $1.58 $1.61 $1.65 $1.69 $1.74 $1.76
Payout Ratio 4.2% 4.4% 5.1% 5.4% 5.7% 6.3% 6.5% 7.8% 8.5% 8.5% 8.7% 9.0% 8.9% 9.3% 9.2% 9.2% 9.3% 9.5% 9.5% 9.5% 9.46%
FCF Payout Ratio 4.5% 4.8% 5.6% 5.7% 6.5% 7.6% 6.6% 8.3% 8.3% 7.7% 7.6% 7.2% 7.0% 7.3% 8.0% 8.9% 9.9% 10.2% 10.1% 9.6% 9.62%
Total Payout Ratio 27.9% 28.1% 32.3% 33.0% 34.0% 36.2% 49.8% 74.3% 78.5% 75.8% 58.8% 58.7% 57.1% 58.2% 72.3% 55.2% 54.8% 24.7% 54.1% 67.8% 67.78%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.15 0.16 0.17 0.18 0.17 0.17 0.15 0.14 0.15 0.15 0.15 0.16 0.14 0.13 0.12 0.11 0.10 0.10 0.09 0.09 0.091
Buyback Yield 1.0% 0.9% 0.8% 0.9% 1.0% 1.1% 1.4% 1.8% 2.0% 2.1% 1.5% 1.4% 1.4% 1.3% 2.0% 1.6% 1.9% 0.6% 1.4% 2.3% 2.27%
Net Buyback Yield 0.9% 0.8% 0.7% 0.8% 0.9% 1.0% 1.4% 1.8% 2.0% 2.1% 1.5% 1.4% 1.4% 1.3% 2.0% 1.6% 1.9% 0.6% 1.4% 2.3% 2.27%
Total Shareholder Return 1.1% 1.0% 0.9% 1.0% 1.1% 1.2% 1.6% 2.0% 2.2% 2.3% 1.7% 1.6% 1.7% 1.5% 2.3% 1.9% 2.3% 0.9% 1.7% 2.6% 2.63%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.86 0.87 0.87 0.88 0.88 0.90 0.91 0.93 0.95 0.95 0.96 0.93 0.92 0.91 0.91 0.93 0.94 0.92 0.92 0.93 0.927
Interest Burden (EBT/EBIT) 0.95 0.95 0.94 0.94 0.93 0.91 0.90 0.86 0.83 0.82 0.80 0.81 0.80 0.80 0.81 0.81 0.82 0.83 0.84 0.85 0.854
EBIT Margin 0.27 0.27 0.24 0.22 0.21 0.19 0.19 0.17 0.17 0.18 0.18 0.19 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.19 0.192
Asset Turnover 0.60 0.61 0.48 0.50 0.52 0.54 0.47 0.46 0.45 0.45 0.44 0.43 0.43 0.43 0.44 0.44 0.44 0.45 0.43 0.44 0.435
Equity Multiplier 1.99 1.99 2.18 2.18 2.18 2.18 2.27 2.27 2.27 2.27 2.16 2.16 2.16 2.16 2.04 2.04 2.04 2.04 2.02 2.02 2.016
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $21.71 $21.57 $19.41 $19.25 $18.88 $17.80 $17.68 $15.53 $14.74 $15.31 $15.45 $15.71 $16.24 $15.98 $16.54 $17.19 $17.42 $17.38 $17.81 $18.39 $18.39
Book Value/Share $87.14 $86.92 $102.49 $103.27 $103.54 $103.27 $111.90 $113.35 $113.35 $113.35 $120.45 $121.71 $122.02 $121.71 $129.46 $130.83 $131.17 $131.17 $141.66 $143.18 $139.62
Tangible Book/Share $-10.76 $-10.74 $-53.46 $-53.87 $-54.00 $-53.87 $-37.39 $-37.88 $-37.88 $-37.88 $-35.97 $-36.34 $-36.44 $-36.34 $-30.81 $-31.14 $-31.22 $-31.22 $-31.28 $-31.62 $-31.62
Revenue/Share $96.59 $98.39 $98.52 $104.11 $108.68 $111.82 $114.29 $112.90 $112.18 $111.91 $110.46 $110.66 $110.56 $110.34 $111.96 $113.19 $114.32 $115.70 $118.19 $121.17 $121.50
FCF/Share $20.54 $19.94 $17.64 $18.31 $16.67 $14.76 $17.59 $14.48 $15.09 $16.87 $17.85 $19.69 $20.79 $20.25 $18.97 $17.74 $16.32 $16.17 $16.69 $18.09 $18.14
OCF/Share $25.89 $25.68 $23.98 $24.73 $23.02 $21.15 $23.29 $19.80 $19.83 $21.06 $21.66 $23.25 $24.41 $23.70 $22.63 $21.47 $20.05 $20.24 $20.74 $22.22 $22.28
Cash/Share $26.07 $26.01 $11.25 $11.33 $11.36 $11.33 $21.69 $21.97 $21.97 $21.97 $20.83 $21.05 $21.10 $21.05 $14.54 $14.70 $14.74 $14.74 $26.82 $27.10 $8.75
EBITDA/Share $32.68 $32.49 $30.06 $30.38 $30.64 $29.76 $30.39 $28.17 $27.42 $28.45 $28.78 $29.77 $30.80 $30.45 $30.65 $30.55 $30.16 $29.98 $30.45 $29.92 $29.92
Debt/Share $56.93 $56.79 $91.30 $92.00 $92.23 $92.00 $91.79 $92.97 $92.97 $92.97 $93.88 $94.85 $95.10 $94.85 $85.57 $86.48 $86.71 $86.71 $108.37 $109.53 $109.53
Net Debt/Share $30.86 $30.78 $80.06 $80.66 $80.87 $80.66 $70.10 $71.00 $71.00 $71.00 $73.04 $73.80 $74.00 $73.80 $71.03 $71.78 $71.97 $71.97 $81.55 $82.43 $82.43
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 3.431
Altman Z-Prime snapshot only 6.342
Piotroski F-Score 9 8 7 5 5 5 6 6 6 6 7 7 8 8 7 7 6 7 6 6 6
Beneish M-Score -2.31 -2.35 -2.02 -2.05 -1.99 -1.94 -2.40 -2.43 -2.52 -2.56 -2.55 -2.61 -2.62 -2.59 -2.64 -2.55 -2.43 -2.55 -2.41 -2.40 -2.400
Ohlson O-Score snapshot only -9.127
Net-Net WC snapshot only $-75.34
EVA snapshot only $-956593996.76
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A-
Credit Score 87.16 86.68 77.97 75.23 75.20 75.28 75.94 72.52 70.67 70.67 72.38 76.27 74.01 75.85 79.28 75.94 75.31 74.14 74.33 69.66 69.662
Credit Grade snapshot only 7
Credit Trend snapshot only -6.276
Implied Spread (bps) snapshot only 175.000
Industry Credit Rank snapshot only 63
Sector Credit Rank snapshot only 66

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms